Skip to main content
Top
Published in: Respiratory Research 1/2013

Open Access 01-12-2013 | Research

Factors associated with change in exacerbation frequency in COPD

Authors: Gavin C Donaldson, Hanna Müllerova, Nicholas Locantore, John R Hurst, Peter MA Calverley, Jorgen Vestbo, Antonio Anzueto, Jadwiga A Wedzicha

Published in: Respiratory Research | Issue 1/2013

Login to get access

Abstract

Background

Patients with chronic obstructive pulmonary disease (COPD) can be categorized as having frequent (FE) or infrequent (IE) exacerbations depending on whether they respectively experience two or more, or one or zero exacerbations per year. Although most patients do not change category from year to year, some will, and the factors associated with this behaviour have not been examined.

Methods

1832 patients completing two year follow-up in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) study were examined at baseline and then yearly. Exacerbations were defined by health care utilisation. Patient characteristics compared between those patients who did or did not change exacerbation category from year 1 to year 2.

Findings

Between years 1 and 2, 221 patients (17%) changed from IE to FE and 210 patients (39%) from FE to IE. More severe disease was associated with changing from IE to FE and less severe disease from FE to IE. Over the preceding year, small falls in FEV1 and 6-minute walking distance were associated with changing from IE to FE, and small falls in platelet count associated with changing from FE to IE.

Conclusion

No parameter clearly predicts an imminent change in exacerbation frequency category.

Trial registration

SCO104960, clinicaltrials.gov identifier NCT00292552
Appendix
Available only for authorised users
Literature
1.
go back to reference Wedzicha JA, Seemungal TA: COPD exacerbations: defining their cause and prevention. Lancet. 2007, 370: 786-796. 10.1016/S0140-6736(07)61382-8.PubMedCrossRef Wedzicha JA, Seemungal TA: COPD exacerbations: defining their cause and prevention. Lancet. 2007, 370: 786-796. 10.1016/S0140-6736(07)61382-8.PubMedCrossRef
2.
go back to reference Wedzicha JA, Donaldson GC: Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003, 48: 1204-1213.PubMed Wedzicha JA, Donaldson GC: Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003, 48: 1204-1213.PubMed
3.
go back to reference Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 157: 1418-1422. 10.1164/ajrccm.157.5.9709032.PubMedCrossRef Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 157: 1418-1422. 10.1164/ajrccm.157.5.9709032.PubMedCrossRef
4.
go back to reference Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA: Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000, 55: 114-120. 10.1136/thorax.55.2.114.PubMedPubMedCentralCrossRef Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA: Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000, 55: 114-120. 10.1136/thorax.55.2.114.PubMedPubMedCentralCrossRef
5.
go back to reference Donaldson G, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002, 57: 847-852. 10.1136/thorax.57.10.847.PubMedPubMedCentralCrossRef Donaldson G, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002, 57: 847-852. 10.1136/thorax.57.10.847.PubMedPubMedCentralCrossRef
6.
go back to reference Soler-Cataluna JJ, Martinez-Garcia MA: Roman Sanchez P, Salcedo E, Navarro M, Ochando R: Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005, 60: 925-931. 10.1136/thx.2005.040527.PubMedPubMedCentralCrossRef Soler-Cataluna JJ, Martinez-Garcia MA: Roman Sanchez P, Salcedo E, Navarro M, Ochando R: Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005, 60: 925-931. 10.1136/thx.2005.040527.PubMedPubMedCentralCrossRef
7.
go back to reference Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, et al: Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010, 363: 1128-1138. 10.1056/NEJMoa0909883.PubMedCrossRef Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, et al: Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010, 363: 1128-1138. 10.1056/NEJMoa0909883.PubMedCrossRef
8.
go back to reference McGuire A, Irwin DE, Fenn P, Gray A, Anderson P, Lovering A, MacGowan A: The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2001, 4: 370-375. 10.1046/j.1524-4733.2001.45049.x.CrossRef McGuire A, Irwin DE, Fenn P, Gray A, Anderson P, Lovering A, MacGowan A: The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2001, 4: 370-375. 10.1046/j.1524-4733.2001.45049.x.CrossRef
9.
go back to reference Borg S, Ericsson A, Wedzicha J, Gulsvik A, Lundback B, Donaldson GC, Sullivan SD: A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease. Value Health. 2004, 7: 153-167. 10.1111/j.1524-4733.2004.72318.x.PubMedCrossRef Borg S, Ericsson A, Wedzicha J, Gulsvik A, Lundback B, Donaldson GC, Sullivan SD: A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease. Value Health. 2004, 7: 153-167. 10.1111/j.1524-4733.2004.72318.x.PubMedCrossRef
10.
go back to reference Quint JK, Donaldson GC, Hurst JR, Goldring JJ, Seemungal TR, Wedzicha JA: Predictive accuracy of patient-reported exacerbation frequency in COPD. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2011, 37: 501-507. 10.1183/09031936.00035909.CrossRef Quint JK, Donaldson GC, Hurst JR, Goldring JJ, Seemungal TR, Wedzicha JA: Predictive accuracy of patient-reported exacerbation frequency in COPD. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2011, 37: 501-507. 10.1183/09031936.00035909.CrossRef
11.
go back to reference Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al: Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary. Am J Respir Crit Care Med. 2013, 187: 347-365. 10.1164/rccm.201204-0596PP.PubMedCrossRef Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al: Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary. Am J Respir Crit Care Med. 2013, 187: 347-365. 10.1164/rccm.201204-0596PP.PubMedCrossRef
12.
go back to reference Donaldson GC, Mullerova H, Locantore NW, Hurst JR, Vestbo J, Anzueto A, Wedzicha JA: Factors Associated With Change In COPD Exacerbation Frequency Phenotype. J Respir Crit Care Med. 2011, 183: A5362- Donaldson GC, Mullerova H, Locantore NW, Hurst JR, Vestbo J, Anzueto A, Wedzicha JA: Factors Associated With Change In COPD Exacerbation Frequency Phenotype. J Respir Crit Care Med. 2011, 183: A5362-
13.
go back to reference Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, et al: Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2008, 31: 869-873. 10.1183/09031936.00111707.CrossRef Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, et al: Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2008, 31: 869-873. 10.1183/09031936.00111707.CrossRef
14.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 16: 5-40.PubMedCrossRef Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 16: 5-40.PubMedCrossRef
15.
go back to reference Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PM, Pinto-Plata V, Celli BR, Tal-Singer R, Wouters EF: Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med. 2010, 104: 849-857. 10.1016/j.rmed.2009.12.007.PubMedCrossRef Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PM, Pinto-Plata V, Celli BR, Tal-Singer R, Wouters EF: Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med. 2010, 104: 849-857. 10.1016/j.rmed.2009.12.007.PubMedCrossRef
16.
go back to reference Enright PL, Sherrill DL: Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998, 158: 1384-1387. 10.1164/ajrccm.158.5.9710086.PubMedCrossRef Enright PL, Sherrill DL: Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998, 158: 1384-1387. 10.1164/ajrccm.158.5.9710086.PubMedCrossRef
17.
go back to reference Celli BR, Cote CG, Marin JM, Casanova C, Montes De Oca M, Mendez RA, Pinto Plata V, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004, 350: 1005-1012. 10.1056/NEJMoa021322.PubMedCrossRef Celli BR, Cote CG, Marin JM, Casanova C, Montes De Oca M, Mendez RA, Pinto Plata V, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004, 350: 1005-1012. 10.1056/NEJMoa021322.PubMedCrossRef
18.
go back to reference Gietema HA, Muller NL, Fauerbach PV, Sharma S, Edwards LD, Camp PG, Coxson HO: Quantifying the extent of emphysema: factors associated with radiologists’ estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol. 2011, 18: 661-671. 10.1016/j.acra.2011.01.011.PubMedCrossRef Gietema HA, Muller NL, Fauerbach PV, Sharma S, Edwards LD, Camp PG, Coxson HO: Quantifying the extent of emphysema: factors associated with radiologists’ estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol. 2011, 18: 661-671. 10.1016/j.acra.2011.01.011.PubMedCrossRef
19.
go back to reference Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R: COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res. 2011, 12: 146-10.1186/1465-9921-12-146.PubMedPubMedCentralCrossRef Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R: COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res. 2011, 12: 146-10.1186/1465-9921-12-146.PubMedPubMedCentralCrossRef
20.
go back to reference Donaldson GC, Seemungal TA, Patel IS, Lloyd-Owen SJ, Wilkinson TM, Wedzicha JA: Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J. 2003, 22: 931-936. 10.1183/09031936.03.00038303.PubMedCrossRef Donaldson GC, Seemungal TA, Patel IS, Lloyd-Owen SJ, Wilkinson TM, Wedzicha JA: Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J. 2003, 22: 931-936. 10.1183/09031936.03.00038303.PubMedCrossRef
21.
go back to reference Aaron SD, Ramsay T, Vandemheen K, Whitmore GA: A threshold regression model for recurrent exacerbations in chronic obstructive pulmonary disease. J Clin Epidemiol. 2010, 63: 1324-1331. 10.1016/j.jclinepi.2010.05.007.PubMedCrossRef Aaron SD, Ramsay T, Vandemheen K, Whitmore GA: A threshold regression model for recurrent exacerbations in chronic obstructive pulmonary disease. J Clin Epidemiol. 2010, 63: 1324-1331. 10.1016/j.jclinepi.2010.05.007.PubMedCrossRef
22.
go back to reference Wilkinson TMA, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA: Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest. 2006, 129: 317-324. 10.1378/chest.129.2.317.PubMedCrossRef Wilkinson TMA, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA: Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest. 2006, 129: 317-324. 10.1378/chest.129.2.317.PubMedCrossRef
23.
go back to reference Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA: Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, 164: 1618-1623. 10.1164/ajrccm.164.9.2105011.PubMedCrossRef Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA: Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, 164: 1618-1623. 10.1164/ajrccm.164.9.2105011.PubMedCrossRef
24.
go back to reference Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Molken MR: Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2010, 5: 435-444.PubMedPubMedCentralCrossRef Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Molken MR: Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2010, 5: 435-444.PubMedPubMedCentralCrossRef
26.
go back to reference Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR: The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2004, 23: 28-33. 10.1183/09031936.03.00034603.CrossRef Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR: The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2004, 23: 28-33. 10.1183/09031936.03.00034603.CrossRef
27.
go back to reference Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA: Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000, 161: 1608-1613. 10.1164/ajrccm.161.5.9908022.PubMedCrossRef Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA: Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000, 161: 1608-1613. 10.1164/ajrccm.161.5.9908022.PubMedCrossRef
28.
go back to reference Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA: Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004, 169: 1298-1303. 10.1164/rccm.200310-1443OC.PubMedCrossRef Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA: Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004, 169: 1298-1303. 10.1164/rccm.200310-1443OC.PubMedCrossRef
29.
go back to reference Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Wang C, Bourbeau J: Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2010, 35: 1022-1030. 10.1183/09031936.00079409.CrossRef Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Wang C, Bourbeau J: Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2010, 35: 1022-1030. 10.1183/09031936.00079409.CrossRef
30.
go back to reference Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, et al: Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010, 11: 122-PubMedPubMedCentral Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, et al: Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010, 11: 122-PubMedPubMedCentral
31.
go back to reference Biljak VR, Pancirov D, Cepelak I, Popovic-Grle S, Stjepanovic G, Grubisic TZ: Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease. Platelets. 2011, 22: 466-470. 10.3109/09537104.2011.573887.PubMedCrossRef Biljak VR, Pancirov D, Cepelak I, Popovic-Grle S, Stjepanovic G, Grubisic TZ: Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease. Platelets. 2011, 22: 466-470. 10.3109/09537104.2011.573887.PubMedCrossRef
32.
go back to reference Vlacha V, Feketea G: Thrombocytosis in pediatric patients is associated with severe lower respiratory tract inflammation. Arch Med Res. 2006, 37: 755-759. 10.1016/j.arcmed.2006.02.009.PubMedCrossRef Vlacha V, Feketea G: Thrombocytosis in pediatric patients is associated with severe lower respiratory tract inflammation. Arch Med Res. 2006, 37: 755-759. 10.1016/j.arcmed.2006.02.009.PubMedCrossRef
34.
go back to reference Ferroni P, Vazzana N, Riondino S, Cuccurullo C, Guadagni F, Davi G: Platelet Function in Health and Disease: from Molecular Mechanisms, Redox Considerations to Novel Therapeutic Opportunities. Antioxid Redox Signal. 2012, 17: 1447-1485. 10.1089/ars.2011.4324.PubMedCrossRef Ferroni P, Vazzana N, Riondino S, Cuccurullo C, Guadagni F, Davi G: Platelet Function in Health and Disease: from Molecular Mechanisms, Redox Considerations to Novel Therapeutic Opportunities. Antioxid Redox Signal. 2012, 17: 1447-1485. 10.1089/ars.2011.4324.PubMedCrossRef
35.
go back to reference Tsai NW, Lin TK, Chang WN, Jan CR, Huang CR, Chen SD, Cheng KY, Chiang YF, Wang HC, Yang TM, et al: Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke. Crit Care. 2011, 15: R163-10.1186/cc10303.PubMedPubMedCentralCrossRef Tsai NW, Lin TK, Chang WN, Jan CR, Huang CR, Chen SD, Cheng KY, Chiang YF, Wang HC, Yang TM, et al: Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke. Crit Care. 2011, 15: R163-10.1186/cc10303.PubMedPubMedCentralCrossRef
36.
go back to reference Huang CC, Chan WL, Chen YC, Chen TJ, Chou KT, Lin SJ, Chen JW, Leu HB: Statin Use and Hospitalization in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Cohort Study in Taiwan. Clin Ther. 2011, 33: 1365-1370. 10.1016/j.clinthera.2011.08.010.PubMedCrossRef Huang CC, Chan WL, Chen YC, Chen TJ, Chou KT, Lin SJ, Chen JW, Leu HB: Statin Use and Hospitalization in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Cohort Study in Taiwan. Clin Ther. 2011, 33: 1365-1370. 10.1016/j.clinthera.2011.08.010.PubMedCrossRef
37.
go back to reference Hernandes NA, Wouters EF, Meijer K, Annegarn J, Pitta F, Spruit MA: Reproducibility of 6-minute walking test in patients with COPD. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2011, 38: 261-267. 10.1183/09031936.00142010.CrossRef Hernandes NA, Wouters EF, Meijer K, Annegarn J, Pitta F, Spruit MA: Reproducibility of 6-minute walking test in patients with COPD. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2011, 38: 261-267. 10.1183/09031936.00142010.CrossRef
38.
go back to reference Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, et al: Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011, 365: 1184-1192. 10.1056/NEJMoa1105482.PubMedCrossRef Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, et al: Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011, 365: 1184-1192. 10.1056/NEJMoa1105482.PubMedCrossRef
39.
go back to reference Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M: A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008, 359: 1543-1554. 10.1056/NEJMoa0805800.PubMedCrossRef Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M: A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008, 359: 1543-1554. 10.1056/NEJMoa0805800.PubMedCrossRef
Metadata
Title
Factors associated with change in exacerbation frequency in COPD
Authors
Gavin C Donaldson
Hanna Müllerova
Nicholas Locantore
John R Hurst
Peter MA Calverley
Jorgen Vestbo
Antonio Anzueto
Jadwiga A Wedzicha
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2013
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-14-79

Other articles of this Issue 1/2013

Respiratory Research 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.